Oncolytics Biotech

$0.00 (0.00%) As of 1:59 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

CEO
Matthew C. Coffey
Employees
25
Headquarters
Calgary, Alberta
Founded
1998

ONCY Key Statistics

Market cap
88.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
299.65K
High today
$1.64
Low today
$1.55
Open price
$1.64
Volume
245.64K
52 Week high
$4.83
52 Week low
$1.55

ONCY Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure